LY2623091, a mineralocorticoid receptor antagonist, is utilized in treating refractory hypertension. It demonstrates CYP3A4-dependent clearance and exhibits synergistic effects when combined with CYP3A4 inhibitors.
Molecular Weight:
527.59
CAS Number:
[1162264-07-4]
Formula:
C30H30FN5O3
Target:
Glucocorticoid Receptor
T88208
* VAT and and shipping costs not included. Errors and price changes excepted
